At the news
? NEUTRALIMPACT 2/10 6-K filed Nov 9, 2026 at 07:46 ET
Davion Healthcare appointed Vienna Capital Partners as financial advisor to support a proposed US$100 million acquisition financing strategy for 2027. The filing is a strategic update with no committed financing, no binding lender commitments, and no financial results reported.
- Davion entered a non-exclusive financial advisory agreement with Vienna Capital Partners LLC.
- Initial aggregate financing objective of US$100 million for acquisitions in 2027.
- No binding lender commitments have been secured; the $100M target is indicative only.
- Company intends to use senior secured, non-convertible debt to minimize equity dilution.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access